-
2022-502154-13-00
5
2023-10-27
Patients with well to moderately differentiated neuroendocrine tumors
-
2023-503582-35-00
6
2023-10-26
Staphylococcus aureus bacteremia
-
2023-503661-28-00
5
2023-10-26
Hidradenitis Suppurativa
-
2022-501057-36-00
5
2023-10-24
ANCA-associated vasculitis
-
2022-502060-21-00
6
2023-10-19
Haemophilia A
-
2022-502299-21-00
1
2023-10-18
Relapsed/refractory (R/R) B-cell and T-cell lymphomas
-
2023-510541-25-00
1
2023-10-09
Relapsed/Refractory B-cell Malignancies
-
2022-501515-14-00
5
2023-09-29
Newly Diagnosed Multiple Myeloma (NDMM)
-
2022-501831-18-00
4
2023-09-13
Patients with hematologic malignancies and undergoing allogenic hemato
-
2022-500933-10-00
11
2023-08-02
Preeclampsia during pregnancy
-
2022-500801-41-00
1
2023-07-26
Relapsed and Refractory Multiple Myeloma
-
2024-519156-93-00
4
2023-07-21
Invasive mechanical ventilation expected to be required for more than
-
2022-500967-11-00
5
2023-07-06
Previously Untreated Metastatic or Unresectable Melanoma
-
2022-501710-62-02
6
2023-06-07
Peripheral T-cell lymphoma (PTCL)
-
2022-500699-76-00
5
2023-05-18
Active Systemic Lupus Erythematosus (SLE)
-
2022-501124-23-00
5
2023-04-18
General anesthesia and sedative and anxiolytic sedation
-
2023-505040-19-00
4
2023-04-11
Non-seminomatous germ-cell tumors (including testis, retroperitoneal a
-
2022-501494-39-00
5
2023-03-28
Uncontrolled Hypertension IN patients with moderate to severe chronic
-
2024-514929-33-00
5
2023-03-27
PANCREATIC FISTULA
-
2022-501238-52-00
10
2023-03-23
Heart failure due to systemic left ventricular systolic dysfunction
-
2022-501171-14-00
3
2023-03-13
adult patients with acute myeloblastic leukemia (AML) of poor prognosi
-
2024-514351-14-00
4
2023-02-20
Pure cell red aplasia by major ABO mismatch after allogeneic hematopoi
-
2023-507233-19-00
10
2023-02-16
Treatment of IgAN
-
2023-509332-26-00
4
2023-02-16
Lupus Nephritis Class III-IV, +/- V